Milton J. Finegold

45.9k total citations · 13 hit papers
386 papers, 33.5k citations indexed

About

Milton J. Finegold is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Milton J. Finegold has authored 386 papers receiving a total of 33.5k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Molecular Biology, 123 papers in Surgery and 106 papers in Genetics. Recurrent topics in Milton J. Finegold's work include Virus-based gene therapy research (56 papers), Liver physiology and pathology (38 papers) and Pediatric Hepatobiliary Diseases and Treatments (37 papers). Milton J. Finegold is often cited by papers focused on Virus-based gene therapy research (56 papers), Liver physiology and pathology (38 papers) and Pediatric Hepatobiliary Diseases and Treatments (37 papers). Milton J. Finegold collaborates with scholars based in United States, Canada and Germany. Milton J. Finegold's co-authors include Markus Grompe, Muhsen Al-Dhalimy, Eric Lagasse, Xin Wang, Allan Bradley, Martin M. Matzuk, Savio L.C. Woo, Francesco J. DeMayo, Mark A. Kay and Richard R. Behringer and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Milton J. Finegold

381 papers receiving 32.7k citations

Hit Papers

Purified hematopoietic stem cells can differentiate into ... 1992 2026 2003 2014 2000 2003 2013 1995 1995 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Milton J. Finegold United States 90 15.4k 9.0k 7.2k 7.1k 6.4k 386 33.5k
Kunio Matsumoto Japan 94 12.6k 0.8× 9.1k 1.0× 2.2k 0.3× 12.6k 1.8× 4.7k 0.7× 683 31.5k
Anita B. Roberts United States 120 31.6k 2.0× 4.9k 0.5× 5.7k 0.8× 2.0k 0.3× 10.4k 1.6× 288 53.4k
Nicholas A. Wright United Kingdom 80 8.9k 0.6× 7.9k 0.9× 3.8k 0.5× 1.5k 0.2× 6.8k 1.1× 462 23.6k
Donna B. Stolz United States 94 15.5k 1.0× 6.3k 0.7× 1.7k 0.2× 3.3k 0.5× 2.6k 0.4× 401 31.6k
Walter Birchmeier Germany 100 30.7k 2.0× 4.2k 0.5× 3.3k 0.5× 4.7k 0.7× 8.4k 1.3× 242 42.4k
Robert J. Coffey United States 98 16.7k 1.1× 5.9k 0.7× 3.3k 0.5× 1.2k 0.2× 7.8k 1.2× 416 34.1k
Johan H. van Es Netherlands 72 23.1k 1.5× 5.8k 0.6× 8.0k 1.1× 2.0k 0.3× 17.7k 2.8× 131 41.4k
Volker Brinkmann Germany 91 19.4k 1.3× 3.6k 0.4× 3.2k 0.4× 1.7k 0.2× 3.4k 0.5× 250 45.3k
Atsushi Miyajima Japan 84 10.3k 0.7× 3.5k 0.4× 1.7k 0.2× 3.3k 0.5× 8.7k 1.4× 364 26.6k
Jesús Prìeto Spain 82 8.7k 0.6× 3.4k 0.4× 3.6k 0.5× 7.9k 1.1× 6.0k 0.9× 606 24.6k

Countries citing papers authored by Milton J. Finegold

Since Specialization
Citations

This map shows the geographic impact of Milton J. Finegold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milton J. Finegold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milton J. Finegold more than expected).

Fields of papers citing papers by Milton J. Finegold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milton J. Finegold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milton J. Finegold. The network helps show where Milton J. Finegold may publish in the future.

Co-authorship network of co-authors of Milton J. Finegold

This figure shows the co-authorship network connecting the top 25 collaborators of Milton J. Finegold. A scholar is included among the top collaborators of Milton J. Finegold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milton J. Finegold. Milton J. Finegold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dorrell, Craig, Qing‐Shuo Zhang, Makiko Mochizuki‐Kashio, et al.. (2024). Long‐term combination therapy with metformin and oxymetholone in a Fanconi anemia mouse model. Pediatric Blood & Cancer. 71(8). e31030–e31030.
2.
Lo, Yuan-Hung, Xi Chen, Christopher S. Williams, et al.. (2019). Growth Factor–Independent 1 Is a Tumor Suppressor Gene in Colorectal Cancer. Molecular Cancer Research. 17(3). 697–708. 41 indexed citations
3.
Harpavat, Sanjiv, Milton J. Finegold, Mary L. Brandt, et al.. (2015). Newborn Direct or Conjugated Bilirubin Measurements As a Potential Screen for Biliary Atresia. Journal of Pediatric Gastroenterology and Nutrition. 62(6). 799–803. 39 indexed citations
4.
Mokkapati, Sharada, Le Huang, E. Cristy Ruteshouser, et al.. (2014). β-Catenin Activation in a Novel Liver Progenitor Cell Type Is Sufficient to Cause Hepatocellular Carcinoma and Hepatoblastoma. Cancer Research. 74(16). 4515–4525. 72 indexed citations
5.
Brunetti‐Pierri, Nicola, Thomas S.C. Ng, David A. Iannitti, et al.. (2013). Transgene Expression up to 7 Years in Nonhuman Primates Following Hepatic Transduction with Helper-Dependent Adenoviral Vectors. Human Gene Therapy. 24(8). 761–765. 63 indexed citations
6.
Magoulas, Pilar, Ayman W. El‐Hattab, Angshumoy Roy, et al.. (2012). Diffuse reticuloendothelial system involvement in type IV glycogen storage disease with a novel GBE1 mutation: a case report and review. Human Pathology. 43(6). 943–951. 21 indexed citations
7.
Brunetti‐Pierri, Nicola, Aimée Liou, Priti N. Patel, et al.. (2012). Balloon Catheter Delivery of Helper-dependent Adenoviral Vector Results in Sustained, Therapeutic hFIX Expression in Rhesus Macaques. Molecular Therapy. 20(10). 1863–1870. 33 indexed citations
8.
Harpavat, Sanjiv, Milton J. Finegold, & Saul J. Karpen. (2011). Patients With Biliary Atresia Have Elevated Direct/Conjugated Bilirubin Levels Shortly After Birth. PEDIATRICS. 128(6). e1428–e1433. 127 indexed citations
9.
Malogolowkin, Marcio H., Howard M. Katzenstein, Rebecka L. Meyers, et al.. (2011). Complete Surgical Resection Is Curative for Children With Hepatoblastoma With Pure Fetal Histology: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 29(24). 3301–3306. 110 indexed citations
10.
Stephen, Sam L., Eugenio Montini, Hans A. Kestler, et al.. (2010). Chromosomal Integration of Adenoviral Vector DNA In Vivo. Journal of Virology. 84(19). 9987–9994. 60 indexed citations
11.
Lu, Li, Ying Li, Soo Mi Kim, et al.. (2010). Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proceedings of the National Academy of Sciences. 107(4). 1437–1442. 586 indexed citations breakdown →
12.
López‐Terrada, Dolores, Preethi H. Gunaratne, Adekunle M. Adesina, et al.. (2009). Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Human Pathology. 40(6). 783–794. 103 indexed citations
13.
Chopra, Atul R., Jean‐François Louet, Pradip Saha, et al.. (2008). Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease. Science. 322(5906). 1395–1399. 133 indexed citations
14.
Marhenke, Silke, Jutta Lamlé, Laura Elisa Buitrago‐Molina, et al.. (2008). Activation of nuclear factor E2‐related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development†. Hepatology. 48(2). 487–496. 30 indexed citations
15.
Toietta, Gabriele, Viraj Mane, Milton J. Finegold, et al.. (2005). Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector. Proceedings of the National Academy of Sciences. 102(11). 3930–3935. 106 indexed citations
16.
Yang, Qi, Nessan Bermingham, Milton J. Finegold, & Huda Y. Zoghbi. (2001). Requirement of Math1 for Secretory Cell Lineage Commitment in the Mouse Intestine. Science. 294(5549). 2155–2158. 724 indexed citations breakdown →
17.
Finegold, Milton J., et al.. (1999). Hepatic veno-occlusive disease in ataxia-telangiectasia. The Journal of Pediatrics. 134(6). 786–788. 12 indexed citations
18.
Kay, Mark A., Qiutang Li, Ta-Jen Liu, et al.. (1992). Hepatic Gene Therapy: Persistent Expression of Human α1-Antitrypsin in Mice after Direct Gene Delivery In Vivo. Human Gene Therapy. 3(6). 641–647. 155 indexed citations
19.
Clift, S, et al.. (1989). Tissue-Specific Regulation of Human α 1 -Antitrypsin Gene Expression in Transgenic Mice. DNA. 8(2). 101–108. 25 indexed citations
20.
Finegold, Milton J. & James L. Bennington. (1986). Pathology of neoplasia in children and adolescents. Saunders eBooks. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026